Scientists at the Scripps Research Institute (TSRI), the University of California (UC), Irvine and The University of Utah report that mice crippled by an autoimmune disease similar to multiple sclerosis (MS) regained the ability to walk and run after a team of researchers implanted human stem cells…
MS lesions
New research work from GlaxoSmithKline presented by Daren Ausin, PhD, at the American Academy of Neurology’s 66th Annual Meeting has implications for individuals with relapsinig-remitting multiple sclerosis. The presentation detailed a study that used GlaxoSmithKline’s ofatumumab in 231 patients with relapse-remitting multiple sclerosis. Ofatumumab is an anti-B-cell antibody, and it…
Recommended Posts
- Mediterranean-style diet may be linked to lower odds of developing MS
- Guest Voice: How phototherapy helped me reclaim my life with MS
- B-cell depletion therapy recruits gut cells to fight MS, study suggests
- Stem cell treatment for progressive MS shows potential to protect the brain
- Study uses lab-grown ‘mini brains’ to explore myelin repair in MS